Good afternoon, and thank you for joining the ReShape Lifesciences third-quarter 2024 Conference Call. I would like to turn the call over to Michael Miller from Rx Communications.

Good afternoon, and thank you for joining the ReShape Lifesciences Third Quarter 2024 Conference Call. I would like to turn the call over to Michael Miller from Rx Communications. Good afternoon, ...

Q3 2024 Earnings Call Transcript November 14, 2024 Operator: Good afternoon, and thank you for joining the ReShape Lifesciences Third Quarter 2024 Conference Call. I would like to turn the call over ...

Trump is expected to make Matt Gaetz his attorney general and Marco Rubio his secretary of state, and place Tulsi Gabbard, ...

Life Science Tools and Diagnostics stocks are viewed favorably at TD Cowen despite concerns over Trump's policies and his HHS ...

The ISO 13485:2016 and MDSAP certifications, issued to Spark Biomedical by DEKRA, recognize the company as both a developer and manufacture. This acknowledgement confirms Spark’s adherence to quality ...

This study presents important findings on cold tolerance shared between hibernating and non-hibernating mammals, identifying a key molecule, GPX4, through multi-species genome-wide CRISPR screens. The ...

A longtime vaccine skeptic, Kennedy is an attorney who has built a loyal following over several decades of people who admire ...

Awarded $14 Million Multi-Year NIH Grant and Initiated Second Clinical Trial for Breakthrough Therapy PF614-MPAR Submitted Pivotal PF614 Phase 3 Protocol to the FDA for Review SAN DIEGO, CA / ...

Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the ...